Download DNB 2016 Dec PAEDIATRICS PAPER 2 Question Paper

FirstRanker.com

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016

--- Content provided by‌ FirstRanker.com ---

Time : 3 hours
Max. Marks :100

--- Content provided by​ FirstRanker.com ---

IMPORTANT INSTRUCTIONS

• This question paper consists of 10 questions divided into Part ‘A’ and Part ‘B’, each part containing 5 questions.
• Answers to questions of Part ‘A’ and Part ‘B’ are to be strictly attempted in separate answer sheet(s) and the main + supplementary answer sheet(s) used for each part must be tagged separately.
• Answers to questions of Part ‘A’ attempted in answer sheet(s) of Part ‘B’ or vice versa shall not be evaluated.
• Answer sheet(s) of Part ‘A’ and Part ‘B’ are not to be tagged together.

--- Content provided by‍ FirstRanker.com ---

• Part ‘A’ and Part ‘B’ should be mentioned only on the covering page of the respective answer sheet(s).
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.

--- Content provided by⁠ FirstRanker.com ---

• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.

PART A

--- Content provided by FirstRanker.com ---

Write short notes on:

1. Clinical features and management of hypoxic ischemic encephalopathy in newborns. (6+4)
2. a) Grading of vesicoureteric reflux. (2+3+5)
   b) Outline the evaluation plan for an infant presenting with UTI.
   c) Treatment of Bowel Bladder Disorder.

--- Content provided by​ FirstRanker.com ---

3. Management of: (5+5)
   a) Hypothermia in newborns.
   b) Apnea in preterms.
4. a) Define Obesity. (2+(3+5))
   b) Enumerate causes and management of childhood obesity.

--- Content provided by FirstRanker.com ---

5. a) Advances in the treatment of thalassemia major. (5+5)
   b) Risk stratification of acute lymphatic leukemia.